Top Markets
Coin of the day
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Classement en actions #5730
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Prix de l'action
$29.86
Dernière synchronisation: 2026-08-19
Capitalisation boursière
$2.48B
Changement (1 jour)
4.92%
Changement (1 an)
502.82%
Pays
TW
Échange Lin BioScience, Inc. (6696)

Catégorie

Historique des divisions d’actions pour Lin BioScience, Inc. (6696)
L’action Lin BioScience, Inc. (symbole : 6696) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 27, 2026.
Une action 6696 achetée avant le Aug 27, 2026 équivaudrait aujourd’hui à 0 actions 6696.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH